Alimera Sciences (ALIM)
(Delayed Data from NSDQ)
$3.28 USD
+0.01 (0.31%)
Updated May 16, 2024 04:00 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
Alimera Sciences, Inc. [ALIM]
Reports for Purchase
Showing records 81 - 96 ( 96 total )
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Positive Signals from the 36-month readout of FAME Study...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Positive Signals from the 36-month readout of FAME Study...
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Discussions with Management & Our Impressions...
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Discussions with Management & Our Impressions....
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Waiting for NDA approval
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Illuvien could present a nice adjunctive therapy in Diabetic Macular Edema
Provider: RODMAN & RENSHAW, CO.
Company: Alimera Sciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.